Primary care sequential use of FIB-4 and the enhanced liver fibrosis test to stratify patients with non-alcoholic fatty liver disease increases cirrhosis detection and reduces referrals of patients with mild disease-2 year study analysis

被引：2

作者：

Srivastava, A. ^{[1
]}

Gailer, R. ^{[2
]}

Demma, S. ^{[1
]}

Warner, A. ^{[3
]}

Suri, D. ^{[4
]}

Morgan, S. ^{[5
]}

Sennett, K. ^{[6
]}

Thorburn, D. ^{[1
]}

Parkes, J. ^{[1
,7
]}

Tsochatzis, E. ^{[1
]}

Rosenberg, W. ^{[1
]}

机构：

[1] UCL Inst Liver & Digest Hlth, Dept Hepatol, London, England

[2] UCL Inst Liver & Digest Hlth, Primary Care & Populat Hlth, London, England

[3] UCL, Primary Care & Populat Hlth, London, England

[4] Whittington Hosp, Dept Hepatol, London, England

[5] Camden CCG, Primary Care, London, England

[6] Islington CCG, Primary Care, London, England

[7] Univ Southampton, Publ Hlth Sci & Med Stat, Southampton, Hants, England

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(17)30397-5

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

PS-121

引用

页码：S68 / S68

页数：1

共 50 条

[31] Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease
Ankur Srivastava
Simcha Jong
Anna Gola
Ruth Gailer
Sarah Morgan
Karen Sennett
Sudeep Tanwar
Elena Pizzo
James O’Beirne
Emmanuel Tsochatzis
Julie Parkes
William Rosenberg
BMC Gastroenterology, 19
[32] Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease
Hirohito Takeuchi
Katsutoshi Sugimoto
Hisashi Oshiro
Kunio Iwatsuka
Shin Kono
Yu Yoshimasu
Yoshitaka Kasai
Yoshihiro Furuichi
Kentaro Sakamaki
Takao Itoi
Journal of Medical Ultrasonics, 2018, 45 : 243 - 249
[33] Smoking Increases the Risk for Cirrhosis and Esophageal Varices Among Patients With Non-Alcoholic Fatty Liver Disease
Krishtopaytis, Eduard
Kumar, Prabhat
Almomani, Ashraf
Onwuzo, Somtochukwu
Boustany, Antoine
Alshaikh, Dana
Albakri, Almaza A.
Alkhayyat, Motasem
Asaad, Imad
Alchirazi, Khaled Alsabbagh
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S907 - S907
[34] FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
Amernia, Behnaz
Moosavy, Seyed Hamid
Banookh, Fatemeh
Zoghi, Ghazal
BMC GASTROENTEROLOGY, 2021, 21 (01)
[35] FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran
Behnaz Amernia
Seyed Hamid Moosavy
Fatemeh Banookh
Ghazal Zoghi
BMC Gastroenterology, 21
[36] Nurse-led model of care to risk-stratify patients with non-alcoholic fatty liver disease
Henry, B.
Elmes, J.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 214 - 214
[37] Diabetes Mellitus Increases the Risk of Significant Hepatic Fibrosis in Patients With Non-alcoholic Fatty Liver Disease
Chhabra, Sandeep
Singh, Arshdeep
Mehta, Varun
Kaur, Amninder
Bansal, Namita
Sood, Ajit
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2022, 12 (02) : 409 - 416
[38] Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
Xie Qingxing
Pan Xiaohui
Zhang Xinyue
Ma Jinfang
Peng Ge
Tong Nanwei
中华医学杂志英文版, 2023, 136 (16)
[39] Histological analysis of hypoglycemic agents on liver fibrosis in patients with non-alcoholic fatty liver disease: a systematic review
Xie, Qingxing
Pan, Xiaohui
Zhang, Xinyue
Ma, Jinfang
Peng, Ge
Tong, Nanwei
CHINESE MEDICAL JOURNAL, 2023, 136 (16) : 2014 - 2016
[40] Real-world use of the FIB-4 calculator in primary care workflows to screen for advanced non-alcoholic fatty liver disease in a large US health system
Therapondos, George
Thomas, Anna
Dieterich, Douglas T.
Girgrah, Nigel
Oravetz, Philip
JOURNAL OF HEPATOLOGY, 2022, 77 : S432 - S432

← 1 2 3 4 5 →